InvestorsHub Logo
Followers 35
Posts 9970
Boards Moderated 0
Alias Born 02/26/2016

Re: Doc328 post# 146648

Saturday, 04/07/2018 8:49:30 AM

Saturday, April 07, 2018 8:49:30 AM

Post# of 464099
You tried.

Analytic discussion is not common.

Most significant takeaway must be universal and
well defined approval.

Presuming to assure "super responder" results
(whether realized or not)
WOULD likely restrict (lacking further study)
authorization to that sub group.

Not quite the Sliced Bread solution predicated by
many share price guesses.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News